SGLT2 inhibitors improved outcomes in stage five chronic kidney disease
1. In this retrospective cohort study, among patients with type 2 diabetes (T2D) and stage five chronic kidney disease (CKD), ...
Tag: chronic kidney disease
#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Personalized therapy does not reduce hospitalization in chronic kidney disease
1. In this randomized controlled trial, algorithmic identification based on electronic health records (EHRs) and practice facilitators did not reduce ...
Albuminuria within high normal range associated with chronic kidney disease progression
1. In this prospective cohort study involving patients with chronic kidney disease (CKD), those with urine albumin levels on the ...
eGFR is more strongly associated with adverse outcomes when cystatin C is included
1. In this cohort study, estimated glomerular filtration rate based on both creatinine and cystatin C (eGFRcr-cys ) was more strongly ...
#VisualAbstract: Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
Click to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Risk of adverse kidney-related events for patients on lithium is low but increases with greater exposure
1. For patients newly initiated on lithium or valproate, the absolute risks of chronic kidney disease (CKD) progression or acute ...
There is a low risk of chronic kidney disease progression following acute kidney injury
1. In this prospective cohort study, there was a limited association between acute kidney injury (AKI) and worsening kidney function ...
Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients
1. The mean eGFR slope was comparable among patients allocated to sodium bicarbonate and placebo over 24 months. 2. Sodium ...
Empagliflozin use is associated with slower progression of chronic kidney disease
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney disease (CKD) as compared ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
